Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05207813 · ClinicalTrials.gov registry record

CLBP Single-Arm Long-Term Follow-up Study

A clinical trial, sponsored by Boston Scientific Corporation.

Completed
Registry status
42
Enrollment target

NCT05207813 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 42 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05207813 has completed, sponsored by Boston Scientific Corporation.

COMPLETED
Registry status
42 participants
Enrollment target

Study Summary

This is a prospective, noninterventional, observational post market data collection of long-term effectiveness and satisfaction outcomes for "A Prospective, Open-Label, Single-Arm Study of Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain (CLBP Single-Arm Study)" population at three (3), four (4), and five (5) years post Intracept Procedure. The working hypothesis is that data collected in this study will demonstrate safety, efficacy, durability and reproducibility of BVN ablation treatment outcomes out to 3, 4, and 5-years post-procedure.

Interventions

  • DEVICE Intracept Procedure

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2022-02-16
Est. Completion 2024-02-01

Sponsor

Boston Scientific Corporation

280 total trials

What the Registry Record Tells You About NCT05207813

The ClinicalTrials.gov registry entry for NCT05207813 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Intracept Procedure is the first listed.

NCT05207813 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05207813 about?

NCT05207813 is a clinical study titled "CLBP Single-Arm Long-Term Follow-up Study". This is a prospective, noninterventional, observational post market data collection of long-term effectiveness and satisfaction outcomes for "A Prospective, Open-Label, Single-Arm Study of Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain (CLBP Single-Arm Study)" p...

What is the current status of trial NCT05207813?

This trial is currently completed. The enrollment target is 42 participants. The study started on 2022-02-16. Estimated completion is 2024-02-01.

What interventions are being tested in trial NCT05207813?

The interventions under investigation include: Intracept Procedure (DEVICE).

Who is sponsoring clinical trial NCT05207813?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.